Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Multiple Sclerosis

Free Subscription 08.12.2025 2 BMC Neurol 1 Brain 1 Eur Neurol 3 J Neurol 5 Mult Scler

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. KAZEMI PAKDEL F, Kazemi Pakdel A, Zarei H, Brian A, et al
   Combined training improves functional capacity, fatigue, and quality of life in individuals with multiple sclerosis: a systematic review and meta-analysis.
   BMC Neurol. 2025 Dec 3. doi: 10.1186/s12883-025-04548.
   PubMed         Abstract available
   
   
2. ZHANG Y, Liu H, Li Z, Zhou M, et al
   A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis.
   BMC Neurol. 2025;25:491.
   PubMed         Abstract available
   
   

   
   Brain

3. WILLARD C, Puglisi L, Ravi D, Dmitrieva M, et al
   Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types.
   Brain. 2025 Dec 2:awaf331. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Eur Neurol

4. WARSZAWER Y, Gal A, Waggoner T, Nissan Y, et al
   Digital Color Vision Testing Reveals Widespread Cone Dysfunction in Multiple Sclerosis Independent of Optic Neuritis.
   Eur Neurol. 2025 Nov 29:1-16. doi: 10.1159/000549814.
   PubMed         Abstract available
   
   

   
   J Neurol

5. ELLINGHAUS CA, Rohling HM, Dorsch EM, Sperber PS, et al
   Anchor-based evaluation of digital motor biomarkers from a 2-year observation in 100 patients with multiple sclerosis.
   J Neurol. 2025;273:4.
   PubMed         Abstract available
   
   
6. HEDSTROM AK, Olsson T, Alfredsson L
   Determinants and prognostic value of onset symptoms in multiple sclerosis.
   J Neurol. 2025;273:2.
   PubMed         Abstract available
   
   
7. WANG Z, Li S, Liu J, Li Y, et al
   Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing-remitting multiple sclerosis: a multi-center validation study.
   J Neurol. 2025;272:792.
   PubMed         Abstract available
   
   

   
   Mult Scler

8. DAUBY S, Dive D, Hansen I, Lommers E, et al
   Cladribine monotherapy in a patient with coexisting Crohn's disease and multiple sclerosis.
   Mult Scler. 2025 Nov 30:13524585251390859. doi: 10.1177/13524585251390859.
   PubMed         Abstract available
   
   
9. BARBUTI E, Pozzilli C, Borriello G, Petracca M, et al
   Addressing autoimmune comorbidities in multiple sclerosis: A case report of ulcerative colitis remission in a patient treated with cladribine tablets.
   Mult Scler. 2025 Nov 30:13524585251396258. doi: 10.1177/13524585251396258.
   PubMed         Abstract available
   
   
10. LU J, Brownlee WJ
    Cladribine: A useful treatment option in multiple sclerosis patients with autoimmune comorbidities.
    Mult Scler. 2025 Nov 30:13524585251396293. doi: 10.1177/13524585251396293.
    PubMed        
    
    
11. KIM TB, Lee JY, Brinker A, Lee PR, et al
    Anaphylaxis and glatiramer acetate.
    Mult Scler. 2025;31:1664-1671.
    PubMed         Abstract available
    
    
12. HARROUD A, Antel JP
    Neuroimmune interactions: How past lessons can inform the present and future of MS care.
    Mult Scler. 2025;31:1611-1618.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.